Will Lewis, Insmed CEO, joins 'Fast Money' to talk Insmed's rare gene therapy development, demand, and quarterly results.

Sarepta said on Monday that its late-stage study testing two gene-targeted therapies for Duchenne muscular dystrophy did not ...

Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...

Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...

Britt Farms’ 300 acres is now home to peanuts, corn, soybeans, pecans, goats, and 150 head of cattle, including his ...

Vinay Prasad, chief of the FDA’s Center for Biologics Evaluation and Research, is planning to publish a paper this month to ...

Acute myeloid leukemia driven by tandem duplications within the UBTF gene (UBTF-TD AML) is a high-risk pediatric cancer in ...

Monday was clean up day for the Indianapolis Colts. After four straight wins and eight games where the game plan was well ...

The consensus estimate for Q3 2025 revenue is $1.38 million, and the earnings are expected to come in at -$0.09 per share.

UC San Diego researchers combined artificial intelligence with molecular biology to unravel how immune cells in the gut ...

Strong enthusiasm for novel modalities is tempered by neurologists’ demands for clinically meaningful endpoints and data superiority, according to .EXTON, PA, Nov. 03, 2025 (GLOBE NEWSWIRE) -- ’ ...

A Northwestern Medicine-led study has identified mutations in the gene CEP76 as a new cause of ciliopathies, shedding light on a complex group of disorders that affect multiple body systems, according ...